Sarayani received the Leadership Service Award, while Desai was awarded the POP Graduate Student Publication Award.
Nduaguba evaluates racial/ethnic disparities related to cancer among people with HIV.
UF College of Pharmacy faculty and students played an important role in leading the 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Please join us in welcoming the 2020-2021 cohort to the department of pharmaceutical outcomes and policy: Ikenna Unigwe, B.S. (Biochemistry/Pharmaceutical Sciences) – Lagos Nigeria (POP previous MS now Ph.D. student) Piaopiao Li, B.S. (Pharmaceutical Science) – China Yehua Wang, B.S. (Microbiology & Immunology) – China Maria Pilar Hernandez-Con, Ph.D. (Health Science)…
Wei “Vivian” Wang, Ph.D., in the department of pharmaceutical outcomes and policy and Haesuk Park, Ph.D., an associate professor in the department, led the study.
Lo-Ciganic’s talk on Sept. 3 will focus on the application of advanced analytics in pharmaceutical outcomes research.
Lo-Ciganic received the award for her paper published in JAMA Network Open that reported on her and her co-authors’ investigation of five different machine learning approaches to predict opioid overdose.
Dr. Hincapie-Castillo has been appointed as a consultant to the FDA's Drug Safety and Risk Management Advisory Committee.
Researchers in the UF College of Pharmacy published the study in JAMA and used a commercial insurance database to examine the trends in the prescribing of preexposure prophylaxis for HIV prevention in the U.S.
Hartzema's study will evaluate a novel software tool developed to inform opioid prescribers of patient risks and therapy benefits.